Zobrazeno 1 - 10
of 48
pro vyhledávání: '"N. C Tassopoulos"'
Autor:
Ioanna Delladetsima, Angelos Hatzakis, George V. Papatheodoridis, N. C. Tassopoulos, Dina Tiniakos
Publikováno v:
Histopathology. 61:881-888
Delladetsima I, Papatheodoridis G V, Tiniakos D G, Hatzakis A & Tassopoulos N C (2012) Histopathology 61, 881–888 Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis Aims: The natural c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2a75b30ecad8f8fd7d643a6b97b3772
https://doi.org/10.1111/j.1365-2559.2012.04294.x
https://doi.org/10.1111/j.1365-2559.2012.04294.x
Autor:
Angelos Hatzakis, Nikolaos K. Gatselis, Sarah P. Georgiadou, George K. Koukoulis, Kalliopi Zachou, N. C. Tassopoulos, Georgios N. Dalekos, Christos Liaskos
Publikováno v:
Alimentary Pharmacology and Therapeutics. 24:1563-1573
Summary Background Development of organ- and non-organ-specific autoantibodies has been reported in hepatitis C virus patients treated with interferon-α plus/minus ribavirin. Aims To address whether prevalence and the titre of gastric parietal autoa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac707e6ca73069269e5e329e28dc3ebc
https://doi.org/10.1111/j.1365-2036.2006.03165.x
https://doi.org/10.1111/j.1365-2036.2006.03165.x
Autor:
Angelos Hatzakis, D. Tsantoulas, N. C. Tassopoulos, G. Hatzis, S. Koutsounas, I. Vafiadis, Evangelos Akriviadis, George V. Papatheodoridis, Giota Touloumi, I. Ketikoglou, Vana Sypsa
Publikováno v:
Publons
Summary. The epidemic of hepatitis C virus (HCV) infection is a major public health issue. We conducted a comprehensive analysis to estimate future HCV-related morbidity and mortality, using a model which is the first to take into account currently a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51294eda8bfcf542e4b7e2a9c77f912d
https://doi.org/10.1111/j.1365-2893.2005.00588.x
https://doi.org/10.1111/j.1365-2893.2005.00588.x
Autor:
N. C. Tassopoulos, J. K. Delladetsima, D. Tsantoulas, Giota Touloumi, G. Hatzis, I. Ketikoglou, Vana Sypsa, Evangelos Akriviadis, Angelos Hatzakis, I. Vafiadis, M. Demonakou
Publikováno v:
Journal of Viral Hepatitis. 11:366-374
Summary. In this study, a comprehensive methodology for modelling the hepatitis C virus (HCV) epidemic is proposed to predict the future disease burden and assess whether the recent decline in the incidence of HCV may affect the future occurrence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83639c924eeb48e5c2305860c1382acb
https://doi.org/10.1111/j.1365-2893.2004.00517.x
https://doi.org/10.1111/j.1365-2893.2004.00517.x
Autor:
S. Vana, George V. Papatheodoridis, Ioanna Delladetsima, Ilias Gountas, Angelos Hatzakis, N. C. Tassopoulos
Publikováno v:
Journal of Hepatology. 64:S459-S460
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d1eadec84d836c1da5d9484fd605d82
https://doi.org/10.1016/s0168-8278(16)00769-8
https://doi.org/10.1016/s0168-8278(16)00769-8
Autor:
S. Kanatakis, I. Ketikoglou, D. Tsantoulas, G. Anagnostopoulos, M. Raptopoulou, Vana Sypsa, G. Hatzis, I. Vafiadis, L. Sidiropoulos, N. C. Tassopoulos, Angelos Hatzakis
Publikováno v:
Journal of Viral Hepatitis. 10:383-389
Summary. A randomized trial was conducted to assess the efficacy of interferon-alpha (IFN) daily in combination with ribavirin in 301 naive patients with chronic hepatitis C (CHC). Patients were randomized to receive ribavirin 1.2 g daily (QD) for 48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::001b7f50188b2bca8de3daa27824d505
https://doi.org/10.1046/j.1365-2893.2003.00439.x
https://doi.org/10.1046/j.1365-2893.2003.00439.x
Autor:
Stephanos J. Hadziyannis, H. Polychronaki, M. Koutelou, N. C. Tassopoulos, M. Paraloglou-Ioannides
Publikováno v:
Journal of Viral Hepatitis. 4:387-394
In spite of the availability of hepatitis B vaccine, acute hepatitis B continues to be a worldwide problem for which no specific therapy is available. We investigated the safety and the effectiveness of recombinant interferon-alpha2b (rIFN-alpha2b) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7f4ba2166375da96259cc4ebcb066b2
https://doi.org/10.1046/j.1365-2893.1997.00072.x
https://doi.org/10.1046/j.1365-2893.1997.00072.x
Autor:
Zissis Moschidis, Antigoni Katsoulidou, N. C. Tassopoulos, Anastasia Karafoulidou, Vana Sypsa, Konstantinos Mimidis, George V. Papatheodoridis, Maria Chini, Angelos Hatzakis
Publikováno v:
Vox sanguinis. 92(1)
The Procleix Ultrio human immunodeficiency virus type 1 (HIV-1)/hepatitis C virus (HCV)/hepatitis B virus (HBV) (Ultrio) assay simultaneously detects HIV-1 RNA, HCV RNA and HBV DNA in individual blood donations. The main objective of the study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57542fc77e5bb39c0facdc4dc6bfe460
https://pubmed.ncbi.nlm.nih.gov/17181585
https://pubmed.ncbi.nlm.nih.gov/17181585
Autor:
Anastasia Karafoulidou, I. Ketikoglou, Vana Sypsa, Antigoni Katsoulidou, G. Hatzis, Athanasios Skoutelis, D. Tsantoulas, Angelos Hatzakis, Themistoklis Vasiliadis, John Boletis, Evangelos Akriviadis, George Kitis, I. Vafiadi, N. C. Tassopoulos, Gkikas Magiorkinis
Publikováno v:
Journal of viral hepatitis. 13(1)
This study aimed to estimate the overall HCV genotype distribution and to reconstruct the HCV genotype-specific incidence in Greece during the recent decades. It also focused at the identification of genotype 4 subtype variability in Greek isolates.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d481be5cf67b3dee5b84c0f99ac0365a
http://ora.ox.ac.uk/objects/uuid:25bffe66-31e6-4f99-8951-0db93e007549
http://ora.ox.ac.uk/objects/uuid:25bffe66-31e6-4f99-8951-0db93e007549
Autor:
Georgios N. Dalekos, Christos Liaskos, Nikolaos K. Gatselis, Kalliopi Zachou, Angelos Hatzakis, N. C. Tassopoulos, Sarah P. Georgiadou
Publikováno v:
World journal of gastroenterology. 11(4)
Various side effects have been reported in patients infected with hepatitis C virus (HCV) who were treated with interferon-alpha (IFN-alpha), including the appearance or exacerbation of underlying autoimmune diseases and the development of a variety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec283e656057483231d20dc8407c79d1
https://pubmed.ncbi.nlm.nih.gov/15641130
https://pubmed.ncbi.nlm.nih.gov/15641130